Standout Papers

FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Li... 2018 2026 2020 2023 578
  1. FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome (2018)
    Robert Q. Le, Liang Li et al. The Oncologist
  2. FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia (2018)
    Aviva C. Krauss, Xin Gao et al. Clinical Cancer Research

Immediate Impact

9 by Nobel laureates 16 from Science/Nature 56 standout
Sub-graph 1 of 21

Citing Papers

The interaction of innate immune and adaptive immune system
2024 Standout
The B7:CD28 family and friends: Unraveling coinhibitory interactions
2024 Standout

Works of Ann T. Farrell being referenced

Systematic Review of PD-1/PD-L1 Inhibitors in Oncology: From Personalized Medicine to Public Health
2021
FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome
2018 Standout

Author Peers

Author Last Decade Papers Cites
Ann T. Farrell 1526 2455 2750 75 6.5k
P. Maslak 1660 2985 2725 96 6.1k
William S. Dalton 2424 4178 3735 119 7.9k
Jean‐François Rossi 3210 2851 2709 109 6.4k
Lothar Bergmann 1381 1339 2021 178 4.7k
Lia Gore 1070 2492 2520 198 6.0k
Martin Sattler 3082 2334 4267 150 8.5k
Benjamin Drewinko 1070 2177 2344 178 5.9k
Robert Justice 714 2481 2757 61 6.3k
Yoichi Imai 1504 1046 2589 181 5.4k
Michael W. Becker 2287 2152 4096 135 7.5k

All Works

Loading papers...

Rankless by CCL
2026